Abstract:Clindamycin, a class of cis-diol-containing compound, is widely used by animal and fishery husbandries to promote healthy growth as well as prevent infections and treat diseases in their produce. Clindamycin can enter human bodies through some food such as milk, meat, etc and affect human health. Thus, it is important to determine clindamycin in animal derived food such as milk and meat. However, direct analysis of clindamycin in these samples is quite difficult because of its very low concentration level and the presence of undesirable matrix effects. It is essential to develop highly efficient pre-treatment materials for selective enrichment of clindamycin. Molecularly imprinted polymers can be well used for specific recognition and selective adsorption of target molecule. In this study, the clindamycin-imprinted magnetic nanoparticles were prepared according to boronate affinity-based oriented surface imprinting. Magnetic nanoparticles and boronic acid ligands were used as supporting materials and functional monomer, respectively. The prepared clindamycin-imprinted magnetic nanoparticles exhibited several significant advantages, such as good specificity, high binding affinity (3.42±0.28)×10-5 M), fast kinetics (6 min) and low binding pH (pH 5.5) toward clindamycin, which made the imprinted material become an ideal sorbent for highly specific enrichment of clindamycin. The reproducibility of clindamycin-imprinted silica nanoparticles was satisfactory. The clindamycin-imprinted silica nanoparticles could be still reused after seven adsorption-desorption cycles, which indicated high chemical stability. In addition, the recoveries of the proposed method for clindamycin at six spiked levels analysis were between 91.2% to 105.3% with the RSD ≤ 5.35%. The prepared clindamycin-imprinted magnetic nanoparticles were successfully applied to the selective separation and enrichment of clindamycin in milk.

Novel clindamycin phosphate hydrate crystal and preparation method thereof

Clindamycin phosphate methanol water solvent compound crystal and preparation method thereof

Novel crystal form (alpha) of clindamycin phosphate, and preparation method

Clindamycin phosphate dimethyl sulfoxide solvent compound crystal and preparation method thereof

Study on the Crystallization Process of Clindamycin Phosphate

Crystallization preparation method of cloxacillin sodium

The preparation of clindamycin phosphate liposome

Novel crystal form of cefuroxime acid and preparation method thereof

Transformations among the New Solid-State Forms of Clindamycin Phosphate

Method for preparing cefotaxime sodium crystal

Solvates and Polymorphs of Clindamycin Phosphate: Structural, Thermal Stability and Moisture Stability Studies

Development of a taste-masked oral suspension of clindamycin HCl using ion exchange resin Amberlite IRP 69 for use in pediatrics

An improved synthesis of clindamycin-2-phosphate by phase transfer catalysis

Crystals of carvidilol dihydric phosphate and preparation method thereof

Dimemorfan phosphate crystal form II and preparation method thereof, and pharmaceutical composition

Ginsenoside C K semihydrate crystal and preparation method thereof

Novel crystal form of argatroban and preparation method thereof

Crystal form of Pravastatin Na, and preparation method and application thereof

Boronate affinity-based clindamycin-imprinted magnetic nanomaterials for rapid, efficient and selective extraction and determination of clindamycin in animal-derived food

Metastable State of Clindamycin Phosphate in Cooling Crystallization

Trace polymer coated clarithromycin spherulites: Formation mechanism, improvement in pharmaceutical properties and development of high-drug-loading direct compression tablets